YAP1 and neoplasm: Given that head and neck squamous cell carcinoma is often characterized by aberrant activation of YAP/TAZ, NDR1/2 kinases may also have significant regulatory roles in this tumor type, where their dysregulation could disrupt Hippo signaling and thereby promote tumor cell proliferation, invasion, and drug resistance.